<DOC>
	<DOCNO>NCT01096940</DOCNO>
	<brief_summary>To assess pharmacokinetics AZD1656 coadministration Simvastatin .</brief_summary>
	<brief_title>Study To Assess Pharmacokinetics AZD1656 During Coadministration With Simvastatin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Patients clinical diagnosis T2DM least 1 year , treat metformin metformin one oral antidiabetic drug ( OAD ) Body mass index great equal 19 less equal 42 kg/m2 HbA1c great 6.5 % enrollment Clinically significant illness clinically relevant trauma , judge Investigator , within 2 week first administration IP Significant cardiovascular event within last 6 month prior enrollment ( eg , myocardial infarction/acute coronary syndrome , revascularisation procedure , stroke transient ischaemic attack ) heart failure New York Heart Association ( NYHA ) class IIIIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Glucose lower</keyword>
</DOC>